Safety

News

More trouble for Astellas as AT132 gene therapy trial is hal...

Astellas has halted dosing in a study of its AT132 gene therapy for the rare disease X-linked myotubular myopathy (XLMTM) for the second time after another serious adverse event (SAE) linke

News

AZ says second COVID jab dose isn't linked to rare clot reac...

A new analysis has suggested that the rare blood clot side effects linked to AstraZeneca's COVID-19 vaccine Vaxzevria don't occur after a second dose.

News

scientifically visualization of a coronavirus spike protein

AZ, J&J tweaking COVID shots to reduce clotting risks; repor...

AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in so

News

FDA adds warning of rare neurological side effect to J&J COV...

The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has been linked to a serious but rare side effect – Guillain-Barré syndrome – that can cause m

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Study links AstraZeneca COVID-19 shot to bleeding disorder I...

Researchers in Scotland have identified a possible link between the Oxford University/AstraZeneca COVID-19 and a mostly mild and generally treatable bleeding disorder.

News

Novartis halts three trials of Beovu eye drug on safety conc...

Prospects for Novartis' ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD).